Candel Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Candel Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q3 2024.
  • Candel Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $614K, a 30.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $614K -$265K -30.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $684K -$256K -27.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $751K -$248K -24.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $816K -$240K -22.7% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $879K -$231K -20.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $940K -$224K -19.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $999K -$216K -17.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.06M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.11M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.16M Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.22M Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.